Tin tức thị trường chứng khoán
Tin tức tài chính mới nhất · Cập Nhật Tháng 5 23, 2026
Apple Tròn 50 Tuổi: Từ Startup Trong Garage Đến Gã Khổng Lồ 3,73 Nghìn Tỷ Đô La—Đây Là Số Tiền Mà Khoản Đầu Tư 1.000 Đô La Tại IPO Của Hãng Sẽ Trị Giá Bao Nhiêu Ngày Nay
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
Tôi Yêu Cầu ChatGPT Giải Thích Ethereum Cho Tôi Như Tôi 12 Tuổi
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
Keir Starmalade, ai không? Liệu mứt cam có thực sự phải được đổi thương hiệu ở UK?
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
Những người sáng tạo TikTok thử nghiệm các tiệm bánh 'đô thị hóa' ở London
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
Goldman Sachs Nâng Mục Tiêu Giá Cổ Phiếu PVH Corp. (PVH) Lên $93 Từ $83
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) Báo cáo Dữ liệu Tuần 52 Tích cực từ Thử nghiệm Giai đoạn 2 New InsiGHTS
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
Wolfe Research bắt đầu đưa BeOne Medicines AG (ONC) vào diện theo dõi với xếp hạng Vượt trội.
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
Mizuho Senker sin Pris Mål på Autolus Therapeutics plc (AUTL) til $10 fra $12
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) Ký Kết Thỏa Thuận với Gilead về Tài Sản Ouro Medicines
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital hạ mục tiêu giá của nó đối với Bicycle Therapeutics plc (BCYC) xuống 7 đô la Mỹ từ 11 đô la Mỹ
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
Các ETF Tốt Nhất Cho Dầu $100 Để Mua Ngay
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen Nâng Mục Tiêu Giá Của Marex Group plc (MRX) Lên $66 Từ $61
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …